Retinoblastoma protein prevents enteric nervous system defects and intestinal pseudo-obstruction

Area of Science:

• Developmental Biology
• Neuroscience
• Genetics

Background:

• The retinoblastoma 1 (RB1) tumor suppressor is crucial for cell cycle control and development.
• Previous research has established RB1's role in various cellular processes, but its specific function in the enteric nervous system (ENS) remains less understood.

Purpose of the Study:

• To investigate the role of RB1 in neural crest-derived melanocytes and the enteric nervous system (ENS).
• To determine the cell-type specific effects of RB1 loss in the ENS.

Main Methods:

• Generated genetically modified mice (TyrCre+;Rb1fl/fl) to specifically delete the Rb1 gene in neural crest-derived cells.
• Analyzed intestinal tissues for defects in the ENS, including glial and neuronal populations, and cell morphology.
• Conducted in vitro studies using shRNA to assess the impact of RB1 knockdown on ENS precursor cells.

Main Results:

• Mice lacking functional RB1 in neural crest derivatives exhibited severe ENS defects, including increased enteric glia and abnormal myenteric neuron nuclei.
• NO-producing myenteric neurons showed endoreplication, leading to enlarged nuclei, resembling features of progeria.
• In vitro experiments confirmed that RB1 loss and nitric oxide (NO) signaling promote DNA replication and nuclear enlargement in ENS precursors.

Conclusions:

• RB1 plays a critical, cell-type specific role in the development and maintenance of the enteric nervous system.
• Dysregulation of RB1 in the ENS can lead to glial hyperplasia and neuronal endoreplication, potentially contributing to gastrointestinal dysfunction.
• The findings link RB1 dysfunction to age-related disorders like progeria through its impact on neuronal nuclear integrity.